Skip to main content
Clinical Trials/CTRI/2023/09/058046
CTRI/2023/09/058046
Not yet recruiting
Phase 4

Quantitative electroencephalogram aspredictor of response to clozapine intreatment resistant schizophrenia. - NI

Government medical college and hospital sector 320 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Government medical college and hospital sector 32
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Government medical college and hospital sector 32

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of schizophrenia according to ICD\-11\.24
  • 2\. Established as Treatment resistant schizophrenia as per Treatment response and resistance
  • in psychosis (TRIPP) working group consensus guidelines3
  • 3\. Patients who have not received clozapine in the past.

Exclusion Criteria

  • 1\. Patients with co\-morbid substance dependence (except nicotine and caffeine)
  • 2\. Patients with history of severe cardiac or renal disorders, or a history of neutropenia,
  • bone\-marrow disorders, paralytic ileus, acute substance\-induced psychosis or
  • intoxication, circulatory collapse or epilepsy.
  • 3\. Patients on any depot I/M drug preparation.
  • 4\. Patients who have received ECT in past 2 weeks.
  • 5\. Patients who are lactating or pregnant.
  • 6\. Patient with any neurological disorders.
  • 7\. Patients with history of seizure in past.
  • 8\. Patients on any immunosuppressant.

Outcomes

Primary Outcomes

Not specified

Similar Trials